STOCK TITAN

[SCHEDULE 13G] InspireMD, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

TL;DR: Declining revenue, restructuring costs and rising leverage overshadow minimal profit.

Q2 shows the core billboard business still contracting and restructuring charges eroding margins. While management avoided new MTA impairments and stayed within covenants, cash burn, higher A/R borrowings and a swing to YTD loss signal pressure on payout sustainability. Investors should watch post-layoff cost savings, ad demand trends and refinancing risk with $400 m term loan due 2026.

TL;DR: Dividend intact, leverage manageable, but growth catalysts limited.

OUT maintains a $0.30 quarterly dividend and sits comfortably inside leverage covenants, giving income investors near-term comfort. Positive free cash flow and unused revolver capacity support liquidity. However, modest top-line declines, limited billboard pricing power and continued MTA drag curb AFFO growth prospects. I classify the filing as neutral: stable but lacking clear upside drivers beyond cost cuts.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Velan Capital Master Fund LP
Signature:/s/ Adam Morgan
Name/Title:Adam Morgan, Managing Member of Velan Capital Holdings LLC, its General Partner
Date:08/06/2025
Velan Capital Holdings LLC
Signature:/s/ Adam Morgan
Name/Title:Adam Morgan, Managing Member
Date:08/06/2025
Velan Capital Investment Management LP
Signature:/s/ Adam Morgan
Name/Title:Adam Morgan, Managing Member of Velan Capital Management LLC, its General Partner
Date:08/06/2025
Velan Capital Management LLC
Signature:/s/ Adam Morgan
Name/Title:Adam Morgan, Managing Member
Date:08/06/2025
Morgan Adam
Signature:/s/ Adam Morgan
Name/Title:Adam Morgan
Date:08/06/2025
Venkataraman Balaji
Signature:/s/ Balaji Venkataraman
Name/Title:Balaji Venkataraman
Date:08/06/2025
Exhibit Information

99.1 - Joint Filing Agreement

Inspiremd

NASDAQ:NSPR

NSPR Rankings

NSPR Latest News

NSPR Latest SEC Filings

NSPR Stock Data

80.82M
19.27M
27.99%
39.21%
1.23%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MIAMI